What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.28%Above 5Y avg (1.54%)
Annual Rate
EUR 4.00Paid annual
Payout Ratio
74.8%Moderate
Payback Period
43.6 yr
Last Ex-Dividend
May 5, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
81.04BEUR
88.91B · vs all stocks (USD)
Updated Nov 20, 2026
Trailing P/E
33.79x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Revenue (TTM)
29.28BEUR
32.13B · vs all stocks (USD)
Updated Nov 20, 2026
Profit Margin
8.52%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Beta
0.5390x
vs all stocks
Updated Nov 20, 2026
52-Week Change
-42.66%
vs all stocks
Updated Nov 20, 2026
Market Capitalization
81.04BEUR
88.91B · vs all stocks (USD)
Updated Nov 20, 2026
Enterprise Value
97.19BEUR
106.63B · vs all stocks (USD)
Updated Nov 20, 2026
Trailing P/E
33.79x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Forward P/E
22.88x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Price to Sales (TTM)
2.83x
vs Medical Instruments & Supplies peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.77×.Updated Nov 20, 2026
Price to Book (MRQ)
2.12x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Enterprise to Revenue
3.32x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Enterprise to EBITDA
16.61x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 14.73×.Updated Nov 20, 2026
Profit Margin
8.52%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Operating Margin
12.81%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Return on Assets (TTM)
3.69%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Return on Equity (TTM)
6.72%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Revenue (TTM)
29.28BEUR
32.13B · vs all stocks (USD)
Updated Nov 20, 2026
Revenue per Share (TTM)
63.46EURUpdated Nov 20, 2026
Quarterly Revenue Growth
5.70%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Gross Profit (TTM)
17.58BEUR
19.29B · vs all stocks (USD)
Updated Nov 20, 2026
EBITDA (TTM)
6.60BEUR
7.24B · vs all stocks (USD)
Updated Nov 20, 2026
Net Income (TTM)
2.49BEUR
2.74B · vs all stocks (USD)
Updated Nov 20, 2026
Quarterly Earnings Growth (YoY)
12.90%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Operating Cash Flow (TTM)
5.29BEUR
5.80B · vs all stocks (USD)
Updated Nov 20, 2026
Levered Free Cash Flow (TTM)
3.29BEUR
3.60B · vs all stocks (USD)
Updated Nov 20, 2026
Trailing Annual Dividend Rate
4.00EURUpdated Nov 20, 2026
Trailing Annual Dividend Yield
2.28%
vs all stocks
Updated Nov 20, 2026
5-Year Average Dividend Yield
1.54%
vs all stocks
Updated Nov 20, 2026
Payout Ratio
74.77%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Minority Interest (Equity)
604.00MEURFY2025 · Dec 31, 2025
Revenue
28.49BEURFY2025 · Dec 31, 2025
Cost of Goods Sold
11.24BEURFY2025 · Dec 31, 2025
Gross Profit
17.25BEURFY2025 · Dec 31, 2025
Operating Income
3.38BEUR
3.70B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
3.19BEURFY2025 · Dec 31, 2025
Income Tax Expense
752.00MEURFY2025 · Dec 31, 2025
Net Income
2.44BEURFY2025 · Dec 31, 2025
EBIT
3.51BEURFY2025 · Dec 31, 2025
EBITDA (Income Statement)
6.60BEURFY2025 · Dec 31, 2025
Research & Development
664.00MEURFY2025 · Dec 31, 2025
Selling, General & Administrative
12.98BEURFY2025 · Dec 31, 2025
Other Operating Expenses
249.00MEURFY2025 · Dec 31, 2025
Non-operating Interest Income
85.00MEURFY2025 · Dec 31, 2025
Non-operating Interest Expense
314.00MEURFY2025 · Dec 31, 2025
EPS (Basic)
5.04EURFY2025 · Dec 31, 2025
EPS (Diluted)
4.98EURFY2025 · Dec 31, 2025
Basic Shares Outstanding
459.02MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
459.02MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
2.44BEURFY2025 · Dec 31, 2025
Minority Interests (P&L)
-128.00MEURFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025
Operating Cash Flow
2.44BEURFY2025 · Dec 31, 2025
Free Cash Flow
922.00MEURFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
3.54BEURFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
2.44BEURFY2025 · Dec 31, 2025
Stock-based Compensation
280.00MEURFY2025 · Dec 31, 2025
Other Non-cash Items
158.00MEURFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-446.00MEURFY2025 · Dec 31, 2025
Capital Expenditures
-1.51BEURFY2025 · Dec 31, 2025
Net Acquisitions
-911.00MEURFY2025 · Dec 31, 2025
Other Investing Activity
12.00MEURFY2025 · Dec 31, 2025
Net Investing Cash Flow
-2.41BEURFY2025 · Dec 31, 2025
Long-term Debt Issuance
992.00MEURFY2025 · Dec 31, 2025
Long-term Debt Payments
-2.47BEURFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
1.50BEURFY2025 · Dec 31, 2025
Common Stock Repurchase
-376.00MEURFY2025 · Dec 31, 2025
Common Dividends Paid
-547.00MEURFY2025 · Dec 31, 2025
Other Financing Charges
1.42BEURFY2025 · Dec 31, 2025
Net Financing Cash Flow
556.00MEURFY2025 · Dec 31, 2025
Shares Outstanding
459.59MSharesUpdated Nov 20, 2026
Float Shares
274.73MSharesUpdated Nov 20, 2026
% Held by Insiders
36.99%
vs all stocks
Updated Nov 20, 2026
% Held by Institutions
27.56%
vs all stocks
Updated Nov 20, 2026
Total Cash (MRQ)
1.93BEUR
2.12B · vs all stocks (USD)
Updated Nov 20, 2026
Total Cash per Share (MRQ)
4.20EURUpdated Nov 20, 2026
Total Debt (MRQ)
15.32BEUR
16.80B · vs all stocks (USD)
Updated Nov 20, 2026
Total Debt to Equity (MRQ)
0.3836x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Current Ratio (MRQ)
0.8890x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Book Value per Share (MRQ)
85.33EURUpdated Nov 20, 2026
Total Assets
63.90BEUR
70.10B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
12.01BEURFY2025 · Dec 31, 2025
Total Liabilities
24.40BEURFY2025 · Dec 31, 2025
Total Non-current Assets
51.89BEURFY2025 · Dec 31, 2025
Total Non-current Liabilities
13.50BEURFY2025 · Dec 31, 2025
Total Current Liabilities
10.90BEURFY2025 · Dec 31, 2025
Cash
3.16BEURFY2025 · Dec 31, 2025
Cash Equivalents
386.00MEURFY2025 · Dec 31, 2025
Cash & Cash Equivalents
3.54BEURFY2025 · Dec 31, 2025
Accounts Receivable
3.64BEURFY2025 · Dec 31, 2025
Inventory
3.54BEURFY2025 · Dec 31, 2025
Accounts Payable
2.88BEURFY2025 · Dec 31, 2025
Short-term Debt
3.68BEURFY2025 · Dec 31, 2025
Other Current Liabilities
1.56BEURFY2025 · Dec 31, 2025
Long-term Debt
10.71BEURFY2025 · Dec 31, 2025
Other Non-current Liabilities
34.00MEURFY2025 · Dec 31, 2025
Common Stock (Book)
83.00MEURFY2025 · Dec 31, 2025
Retained Earnings
2.31BEURFY2025 · Dec 31, 2025
Total Shareholders' Equity
39.49BEUR
43.33B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
25.00MEURFY2025 · Dec 31, 2025
52-Week Low
138.30EURUpdated Nov 20, 2026
52-Week High
317.00EURUpdated Nov 20, 2026
52-Week Change
-42.66%
vs all stocks
Updated Nov 20, 2026
Beta
0.5390x
vs all stocks
Updated Nov 20, 2026
50-Day MA
160.85EURUpdated Nov 20, 2026
200-Day MA
178.85EURUpdated Nov 20, 2026
Avg 10-Day Volume
804.54KSharesUpdated Nov 20, 2026
Avg 30-Day Volume
894.20KSharesUpdated Nov 20, 2026
Diluted EPS (TTM)
5.35EURUpdated Nov 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 0.89×, lower than 95% of its Medical Instruments & Supplies peers (median 2.7×)Significant
Current ratio: 0.89Industry median: 2.70Industry P5: 1.19Peers compared: 35.00
Financial Health
Altman Z-Score 2.69: safe zoneNotable
Altman Z-Score: 2.69
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $88.91B, higher than 95% of all stocks globallySignificant
Market cap (USD): 88,911,591,388.451Global P95: 25,915,547,689.943
Revenue is $32.13B, higher than 95% of all stocks globallySignificant